215 related articles for article (PubMed ID: 15006970)
1. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis.
Evans SE; Colby TV; Ryu JH; Limper AH
Chest; 2004 Mar; 125(3):1063-70. PubMed ID: 15006970
[TBL] [Abstract][Full Text] [Related]
2. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
3. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.
Matsumoto Y; Horiba K; Usuki J; Chu SC; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):327-36. PubMed ID: 10460750
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies of lymphangioleiomyomatosis.
Black JL; Ge Q; Boustany S; Johnson PR; Poniris MH; Glanville AR; Oliver BG; Moir LM; Burgess JK
Eur Respir J; 2005 Oct; 26(4):569-76. PubMed ID: 16204585
[TBL] [Abstract][Full Text] [Related]
5. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
Kristof AS; You Z; Han YS; Giaid A
Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
[TBL] [Abstract][Full Text] [Related]
6. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
Merrilees MJ; Hankin EJ; Black JL; Beaumont B
J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic analysis of pulmonary lymphangioleiomyomatosis].
Lü Y; Liao SL; Tang XN; Ye Q; Zhang L; Zhao HY
Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):84-7. PubMed ID: 15842802
[TBL] [Abstract][Full Text] [Related]
8. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF
Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434
[TBL] [Abstract][Full Text] [Related]
9. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.
Matsui K; Takeda K; Yu ZX; Travis WD; Moss J; Ferrans VJ
Arch Pathol Lab Med; 2000 Feb; 124(2):267-75. PubMed ID: 10656737
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis.
Limper AH; Colby TV; Sanders MS; Asakura S; Roche PC; DeRemee RA
Am J Respir Crit Care Med; 1994 Jan; 149(1):197-204. PubMed ID: 8111583
[TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis.
Kumasaka T; Seyama K; Mitani K; Sato T; Souma S; Kondo T; Hayashi S; Minami M; Uekusa T; Fukuchi Y; Suda K
Am J Surg Pathol; 2004 Aug; 28(8):1007-16. PubMed ID: 15252306
[TBL] [Abstract][Full Text] [Related]
12. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
[TBL] [Abstract][Full Text] [Related]
13. Expression of fibronectin and TGF-beta1 mRNA and protein suggest altered regulation of extracellular matrix in degenerated disc tissue.
Nerlich AG; Bachmeier BE; Boos N
Eur Spine J; 2005 Feb; 14(1):17-26. PubMed ID: 15340826
[TBL] [Abstract][Full Text] [Related]
14. Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry.
Schoolmeester JK; Park KJ
Am J Surg Pathol; 2015 Oct; 39(10):1404-10. PubMed ID: 26135558
[TBL] [Abstract][Full Text] [Related]
15. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan Controls the Deposition of Fibronectin and Collagen and Modulates TGF-β1 Induction of Lung Myofibroblasts.
Evanko SP; Potter-Perigo S; Petty LJ; Workman GA; Wight TN
Matrix Biol; 2015 Mar; 42():74-92. PubMed ID: 25549589
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].
Kuhnen C; Preisler K; Müller KM
Pathologe; 2001 May; 22(3):197-204. PubMed ID: 11402850
[TBL] [Abstract][Full Text] [Related]
18. Distribution and mRNA expression of insulin-like growth factor system in pulmonary lymphangioleiomyomatosis.
Valencia JC; Matsui K; Bondy C; Zhou J; Rasmussen A; Cullen K; Yu ZX; Moss J; Ferrans VJ
J Investig Med; 2001 Sep; 49(5):421-33. PubMed ID: 11523698
[TBL] [Abstract][Full Text] [Related]
19. Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response.
Miller S; Stewart ID; Clements D; Soomro I; Babaei-Jadidi R; Johnson SR
J Pathol Clin Res; 2020 Jul; 6(3):215-226. PubMed ID: 32352655
[TBL] [Abstract][Full Text] [Related]
20. Small airways morphological alterations associated with functional impairment in lymphangioleiomyomatosis.
Mendonça LP; Costa NSX; do Nascimento ECT; de Oliveira MR; de Carvalho CRR; Baldi BG; Dolhnikoff M
BMC Pulm Med; 2024 Jan; 24(1):22. PubMed ID: 38195527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
